Cylindromatosis (CYLD) inhibits Streptococcus pneumonia-induced plasminogen activator inhibitor-1 expression via

Jing Wu1, Jing Zhao1, Jie Yu1

  • 1Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, 200040, China.

Insights

Streptococcus pneumoniae (S. pneumoniae) lung infections involve plasminogen activator inhibitor-1 (PAI-1), regulated by cylindromatosis (CYLD). CYLD inhibits PAI-1 by deubiquitinating tumor necrosis factor receptor-associated factor 6 (TRAF-6).

Area of Science:

  • Immunology
  • Molecular Biology
  • Pulmonology

Background:

  • Streptococcus pneumoniae (S. pneumoniae) is a leading cause of community-acquired pneumonia.
  • S. pneumoniae infection is linked to plasminogen activator inhibitor-1 (PAI-1) expression, which mitigates acute lung injury.
  • Cylindromatosis (CYLD) negatively regulates S. pneumoniae-induced PAI-1 effects.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which CYLD regulates S. pneumoniae-induced PAI-1 expression.
  • To investigate the role of tumor necrosis factor receptor-associated factor 6 (TRAF-6) signaling in this pathway.

Main Methods:

  • Si-RNA mediated knockdown of TRAF-6.
  • Over-expression of wild-type (wt-) and mutated CYLD and TRAF-6.
  • Co-immunoprecipitation (co-IP) assays.
  • Confocal microscopy.

Main Results:

  • S. pneumoniae-induced PAI-1 expression is dependent on TRAF-6 signaling.
  • Knockdown of TRAF-6 significantly inhibited S. pneumoniae-induced PAI-1 expression.
  • CYLD directly associates with TRAF-6.
  • Over-expression of wt-CYLD inhibited TRAF-6 ubiquitination and PAI-1 expression, while mutated CYLD enhanced it.

Conclusions:

  • TRAF-6 mediates S. pneumoniae-induced PAI-1 expression.
  • CYLD inhibits PAI-1 expression by deubiquitinating TRAF-6.
  • These findings offer molecular insights into CYLD's role in S. pneumoniae-induced PAI-1 expression and potential acute lung injury modulation.

Related Concept Videos

Cytoskeletal Linker Proteins - Plakins01:09

Cytoskeletal Linker Proteins - Plakins

Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...
3.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
14.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.5K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.8K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K